高级检索
当前位置: 首页 > 详情页

Immune checkpoint inhibitors for advanced oesophageal cancer treated with surgery, radiotherapy or chemotherapy

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Epidemiology, School of Public Health and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. [2]West China Biomedical Big Data Center, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China. [3]Center of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. [4]State Key Laboratory of Genetic Engineering, Human Phenome Institute, and School of Life Sciences, Fudan University, Shanghai, China. [5]Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
出处:

摘要:
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICIs) for people with advanced, unresectable or metastatic oesophageal cancer.Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版
大类 | 2 区 医学
小类 | 2 区 医学:内科
最新[2025]版
大类 | 2 区 医学
小类 | 2 区 医学:内科
第一作者:
第一作者机构: [1]Department of Epidemiology, School of Public Health and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Epidemiology, School of Public Health and Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. [5]Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:65763 今日访问量:1 总访问量:5149 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号